High concentrations of nirmatrelvir/ritonavir in critically ill patients receiving continuous renal replacement therapy
Description
Nirmatrelvir/ritonavir is a highly efficacious agent against severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection. Although dose adjustment is recommended in patients with renal impairment according to the package insert of Paxlovid
